Differentiation between high-grade glioma and metastatic brain tumor using single-voxel proton MR spectroscopy

被引:127
作者
Ishimaru, H
Morikawa, M
Iwanaga, S
Kaminogo, M
Ochi, M
Hayashi, K
机构
[1] Nagasaki Univ, Sch Med, Dept Radiol, Nagasaki 8528501, Japan
[2] Nagasaki Univ, Sch Med, Dept Neurosurg, Nagasaki 8528501, Japan
关键词
magnetic resonance spectroscopy; glioma; metastasis;
D O I
10.1007/s003300000814
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The purpose of this study was to clarify the efficacy of single-voxel proton magnetic resonance spectroscopy (MRS) in differentiating high-grade glioma from metastasis. Thirty-one high-grade gliomas (11 anaplastic gliomas and 20 glioblastomas) and 25 metastases were studied. Proton MRS was performed using point-resolved spectroscopy with echo times (TEs) of both 136 and 30 ms. The peaks for lipid were evaluated at short TE, and those for N-acetyl-aspartate (NAA), creatine (Cr), and choline-containing compounds (Cho) were assessed at long TE. All the tumors exhibited a strong Cho peak at long TE. Twenty-one of 25 metastases showed no definite Cr peak. The remaining 4 metastases showed NAA and Cr peaks; however, the presence of NAA and relatively high NAA/ Cr ratio (1.58 +/- 0.56) indicated normal brain contamination. All the gliomas except for a single glioblastoma, showed a Cr peak with (n = 16) or without (n = 14) NAA. At short TE all metastases and glioblastomas showed definite lipid or lipid/lactate mixture, but anaplastic gliomas showed no definite lipid signal. Intratumoral Cr suggests glioma. Absence of Cr indicates metastasis. Definite lipid signal indicates cellular necrosis in glioblastoma and metastasis, and no lipid signal may exclude metastases.
引用
收藏
页码:1784 / 1791
页数:8
相关论文
共 41 条
  • [1] Bendszus M, 2000, AM J NEURORADIOL, V21, P375
  • [2] PHOSPHATE METABOLITE IMAGING AND CONCENTRATION MEASUREMENTS IN HUMAN HEART BY NUCLEAR-MAGNETIC-RESONANCE
    BOTTOMLEY, PA
    HARDY, CJ
    ROEMER, PB
    [J]. MAGNETIC RESONANCE IN MEDICINE, 1990, 14 (03) : 425 - 434
  • [3] PRACTICAL APPLICATIONS OF CHEMICAL-SHIFT IMAGING
    BROWN, TR
    [J]. NMR IN BIOMEDICINE, 1992, 5 (05) : 238 - 243
  • [4] NONINVASIVE DIFFERENTIATION OF TUMORS WITH USE OF LOCALIZED H-1 MR SPECTROSCOPY INVIVO - INITIAL EXPERIENCE IN PATIENTS WITH CEREBRAL-TUMORS
    BRUHN, H
    FRAHM, J
    GYNGELL, ML
    MERBOLDT, KD
    HANICKE, W
    SAUTER, R
    HAMBURGER, C
    [J]. RADIOLOGY, 1989, 172 (02) : 541 - 548
  • [5] Castillo M, 1996, AM J NEURORADIOL, V17, P1
  • [6] LOCALIZED H-1-NMR SPECTROSCOPY IN 50 CASES OF NEWLY DIAGNOSED INTRACRANIAL TUMORS
    DEMAEREL, P
    JOHANNIK, K
    VANHECKE, P
    VANONGEVAL, C
    VERELLEN, S
    MARCHAL, G
    WILMS, G
    PLETS, C
    GOFFIN, J
    VANCALENBERGH, F
    LAMMENS, M
    BAERT, AL
    [J]. JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1991, 15 (01) : 67 - 76
  • [7] Proton magnetic resonance spectroscopy and intracranial tumours: Clinical perspectives
    Falini, A
    Calabrese, G
    Origgi, D
    Lipari, S
    Triulzi, F
    Losa, M
    Scotti, G
    [J]. JOURNAL OF NEUROLOGY, 1996, 243 (10) : 706 - 714
  • [8] MAPPING OF BRAIN-TUMOR METABOLITES WITH PROTON MR SPECTROSCOPIC IMAGING - CLINICAL RELEVANCE
    FULHAM, MJ
    BIZZI, A
    DIETZ, MJ
    SHIH, HHL
    RAMAN, R
    SOBERING, GS
    FRANK, JA
    DWYER, AJ
    ALGER, JR
    DICHIRO, G
    [J]. RADIOLOGY, 1992, 185 (03) : 675 - 686
  • [9] Furuya S, 1997, NMR BIOMED, V10, P25, DOI 10.1002/(SICI)1099-1492(199701)10:1<25::AID-NBM445>3.0.CO
  • [10] 2-M